Browse the evidence

Long-term Estrogen Replacement Therapy (ERT) in postmenopausal women is associated with larger contractile cross-sectional area compared to non-ERT women, though it does not significantly affect intramuscular fat content.

For postmenopausal women, long-term ERT may help preserve muscle mass (contractile area), though it does not appear to reduce intramuscular fat. This is a preliminary finding with a small sample size, so decisions about ERT should be made with a doctor based on individual health risks and benefits.

Intranasal insulin administration improves memory and cognitive function in early Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) patients, particularly those who are ApoE-ε4 negative.

If you have early memory issues, ask your doctor about intranasal insulin trials. It may help memory, especially if you don't carry the ApoE-ε4 gene. It is safer than systemic insulin injections because it targets the brain directly without causing dangerous blood sugar drops.

GLP-1 analogues (e.g., liraglutide, exenatide) show promise in animal models for reducing amyloid plaques, tau phosphorylation, and improving cognition, but human clinical trials have shown mixed or disappointing results so far.

GLP-1 drugs (like Ozempic/Wegovy) are being studied for Alzheimer's. While they work well in mice, human trials have not yet confirmed they improve memory or reduce brain plaques. Do not expect them to cure AD yet, but maintaining metabolic health with these drugs may still offer some neuroprotective benefits.

Higher doses (10-15 mg) of the dual GIP/GLP-1 receptor agonist tirzepatide significantly improve specific nonalcoholic steatohepatitis (NASH) biomarkers, including reducing hepatocyte apoptosis (K-18) and fibrosis (Pro-C3), and increasing anti-fibrogenic adiponectin, in patients with type 2 diabetes.

If you have Type 2 Diabetes, higher doses of tirzepatide (10-15 mg weekly) have been shown to improve blood markers associated with liver inflammation and scarring (NASH) compared to placebo. However, this is based on blood tests, not liver biopsies, so it indicates reduced liver stress rather than a confirmed cure for liver disease. Consult your doctor to see if this medication is appropriate for your metabolic health.

Chronic exposure to high levels of arsenic in drinking water (typically >100 ppb) is associated with a significantly increased risk of developing type 2 diabetes, with a pooled relative risk of 2.52 in high-exposure populations.

If you live in an area with known high arsenic levels in your drinking water (often >100 ppb), your risk of developing type 2 diabetes is significantly higher (more than double) compared to those with low exposure. This risk is specifically linked to chronic exposure via drinking water in endemic areas like parts of Taiwan and Bangladesh. Ensure your water source is tested and consider filtration or alternative sources if arsenic levels are high.

Acetate, a primary SCFA, crosses the blood-brain barrier to directly stimulate the hypothalamic arcuate nucleus, increasing POMC (anorexigenic) and decreasing AgRP (orexigenic) neuron expression.

Ensure adequate intake of fermentable fibers to generate acetate. While the direct brain effect is confirmed in animals, the practical application relies on the cumulative effect of high fiber intake.

In moderately obese men, elevated circulating free fatty acid (FFA) levels drive the accumulation of triglycerides within the myocardium and epicardial fat, a process that precedes left ventricular hypertrophy and overload.

For individuals with obesity, high levels of free fatty acids in the blood can lead to fat storage inside the heart muscle, even before heart function declines. This suggests that managing overall metabolic health and fatty acid availability is crucial for preventing early cardiac structural changes.

Metformin is a common pharmacological insulin sensitization therapy used to treat PCOS, though specific dosing protocols are not detailed in this review excerpt.

Metformin is a standard medication for treating insulin resistance in PCOS. Consult a doctor for appropriate dosing and monitoring.

Ketone bodies (specifically beta-hydroxybutyrate) act as signaling molecules that inhibit histone deacetylases (HDACs) and promote histone acetylation, thereby altering gene expression to support anti-oxidant and anti-inflammatory pathways.

This is a deep molecular mechanism. Practically, it means that the ketone bodies your body makes on a low-carb diet are actively turning on genes that protect your cells from aging and damage.

Sarcopenia and obesity in aging are linked to immune senescence through a common mechanism of decreased IL-15 (myokine) and increased pro-inflammatory adipokines, which negatively regulate Natural Killer (NK) cell survival and function.

Maintaining muscle mass through resistance training and managing body fat are critical for preserving immune function as you age. This is achieved by supporting healthy levels of IL-15 (from muscle) and reducing pro-inflammatory signals from fat tissue, which together protect Natural Killer cells.

Delta sleep-inducing peptide (DSIP), uridine, oxidized glutathione, and muramyl peptides were identified as early 'sleep factors' through transfer experiments, but they lack a determined physiological sleep regulatory role compared to adenosine and PGD2.

Early research identified several substances like DSIP and uridine that could induce sleep when transferred between animals, but their natural role in regulating sleep in the body remains unclear compared to more recently identified factors like adenosine.

Obesity-induced adipose tissue hypoxia and hypertrophy drive a pro-inflammatory adipokine profile (high leptin/TNF-a/IL-6, low adiponectin) that creates a permissive microenvironment for tumor initiation, progression, and metastasis.

Maintaining a healthy weight reduces the risk of obesity-related cancers by preventing the physiological state of adipose hypoxia and chronic inflammation. This involves managing body fat to avoid the hormonal imbalances (high leptin, low adiponectin) that fuel tumor growth.

Low levels of adiponectin, common in obesity, remove a protective anti-tumor effect, thereby facilitating cancer development and progression.

Improving adiponectin levels through weight management may help restore anti-tumor defenses. This involves reducing visceral fat to normalize adipokine secretion.

Elevated leptin levels in obesity promote cancer cell survival, proliferation, and migration by inducing anti-apoptotic, pro-inflammatory, and angiogenic factors.

Managing obesity helps lower leptin levels, which may reduce the stimulation of cancer cell growth and survival pathways.

Exposure to endocrine-disrupting chemicals (EDCs) during early development can alter adipose tissue homeostasis and energy regulation, predisposing individuals to obesity and metabolic syndrome even with low-calorie diets and increased physical activity.

If you are struggling with weight loss despite diet and exercise, consider your environmental exposure to endocrine disruptors (found in plastics, pesticides, and certain consumer products). While you cannot control all environmental factors, minimizing exposure to plastics (e.g., avoiding heating food in plastic) and choosing fresh over processed foods may support metabolic health, especially if you were exposed to these chemicals during early development.

Exposure to specific endocrine-disrupting chemicals (e.g., phthalates, BPA, vinclozolin) is associated with an increased risk of Testicular Dysgenesis Syndrome (TDS) and reduced male fertility.

For men concerned about fertility, minimizing exposure to known endocrine disruptors like phthalates and BPA (found in some plastics and receipts) is advisable, especially if planning a family. This is particularly relevant for those with a history of reproductive issues, as early developmental exposure may have lasting effects.

Mitochondrial overload of fatty acid oxidation in muscle, characterized by incomplete oxidation and accumulation of acylcarnitines, causes insulin resistance by depleting TCA cycle intermediates and inducing mitochondrial stress, rather than solely by the accumulation of diacylglycerols and ceramides.

When consuming high-fat diets, the body's ability to burn fat in muscle mitochondria can become overwhelmed, leading to metabolic stress and insulin resistance. This suggests that managing lipid flux and supporting mitochondrial health (e.g., through exercise which normalizes acylcarnitines) is crucial, rather than just avoiding fat entirely.

Administration of Akkermansia muciniphila improves glucose metabolism and reduces fasting hyperglycemia in type 2 diabetic mouse models by decreasing gluconeogenesis.

Current research shows the bacterium Akkermansia muciniphila improves blood sugar control in diabetic mice, but it is not yet a confirmed or available probiotic treatment for humans.

Visfatin (Nampt) promotes cancer cell survival and migration through inflammatory, metabolic, and antioxidant pathways, particularly in colorectal and ovarian cancers.

Visfatin is a molecule that increases with obesity and can promote cancer cell survival and spread, especially in colorectal and ovarian cancers. Reducing obesity may help lower visfatin levels, potentially slowing cancer progression.

Dietary capsaicin (0.01%) prevents diet-induced obesity in wild-type mice by activating TRPV1 channels, which triggers intracellular calcium elevation and subsequent phosphorylation of CaMKII and AMPK, leading to SIRT-1 activation, PPARγ deacetylation, and the browning of white adipose tissue (WAT).

This research suggests that adding a small amount of capsaicin (0.01% of diet) to a high-fat diet can prevent obesity in mice by turning white fat into energy-burning brown fat. This happens through a specific chain reaction starting with TRPV1 activation. For humans, this implies that spicy foods might support metabolic health, but the dose required in the study is specific and the sensory experience is intense. It does not mean you can eat unlimited fat; it means capsaicin may help mitigate some effects of a poor diet by increasing energy expenditure.

Inhibition of SIRT4 in liver and muscle cells increases fatty acid oxidation and mitochondrial gene expression, primarily through the upregulation of SIRT1 and activation of AMPK.

This research suggests that reducing SIRT4 activity could help the liver and muscles burn more fat. This mechanism is currently being explored for potential treatments for type 2 diabetes and conditions involving ectopic fat storage, but no direct human intervention is available yet.

Chronic low-dose aspartame consumption impairs insulin-stimulated glucose disposal and elevates fasting glucose in diet-induced obese rats, independent of changes in body composition.

Even at low doses, chronic aspartame consumption may worsen blood sugar control and insulin sensitivity, regardless of weight loss. If you are managing diabetes or insulin resistance, consider reducing or eliminating aspartame, as it may be contributing to your metabolic issues through gut microbiome changes.

Low-dose aspartame consumption increases serum propionate levels, which may drive hepatic gluconeogenesis and impair insulin tolerance.

Aspartame may increase propionate, a gut-derived metabolite that can raise blood sugar. This suggests that avoiding aspartame might help manage blood sugar levels, especially if you have insulin resistance.

Serum Anti-Mullerian Hormone (AMH) can be used as an alternative to ultrasound for defining Polycystic Ovarian Morphology (PCOM) in adults, but should not be used as a single test or in adolescents.

In adults, AMH blood tests can help confirm PCOS if ultrasound isn't possible or preferred, but it is never used alone. It is not recommended for adolescents. Discuss with your doctor if it fits your diagnostic pathway.